Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Rocket Doctor AI ( (TSE:AIDR) ).
Rocket Doctor AI has completed the acquisition of Alea Health Holdings, adding therapist-led mental health capabilities and complementary clinical workflow and decision-support technology to its AI-driven digital health platform. The all-share-and-cash deal, which includes assumption of a limited SAFE-related obligation but no long-term liabilities, will see Alea’s team and technology integrated into Rocket Doctor AI’s product roadmap, bolstering its physician-led marketplace and strengthening its strategic position in virtual care by enhancing clinical efficiency, care consistency and patient outcomes for North American patients, especially in underserved and remote regions.
The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.73 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.
Spark’s Take on TSE:AIDR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.
The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.
To see Spark’s full report on TSE:AIDR stock, click here.
More about Rocket Doctor AI
Rocket Doctor AI Inc. is a Vancouver-based digital health company that develops physician-built, AI-powered solutions to improve access to high-quality healthcare across the patient journey. Its proprietary Global Library of Medicine underpins a clinical decision support system aimed at enhancing care quality and consistency, with a particular focus on underserved and remote communities across Canada and the United States.
Average Trading Volume: 214,489
Technical Sentiment Signal: Buy
Current Market Cap: C$64.58M
For detailed information about AIDR stock, go to TipRanks’ Stock Analysis page.